Clinical Trials Browser

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06822829 2025-02-12

REVERSE_2021

Recruiting

50 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT06307600 2025-01-23

The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

Phase EARLY_PHASE1 Recruiting

9 enrolled

Lymphoid

Lymphoma

NCT06758713 2025-01-06

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

Phase 1 Recruiting

60 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Lymphoma, B-Cell, Hematologic Neoplasms

NCT06362707 2024-10-22

FEAD

Phase 2 Recruiting

200 enrolled

Lymphoid

Alzheimer Disease, Lymphoma, Follicular, Cognitive Dysfunction

NCT06478381 2024-06-27

L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma

Phase 1 Recruiting

22 enrolled

Lymphoid

Lymphoma, B-Cell

NCT06056752 2023-10-24

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Phase 1 Recruiting

10 enrolled

Lymphoid

Burkitt Lymphoma

NCT05963347 2023-09-01

Go-CHOP as the Frontline Therapy for PTCL

Phase 2 Recruiting

45 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT05982223 2023-08-08

Integrative Medicine in Lymphoma Survivors

Phase NA Recruiting

90 enrolled

Lymphoid

Lymphoma

NCT05648019 2023-03-09

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

Phase 2 Recruiting

40 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05528887 2022-09-06

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Phase 1 Recruiting

10 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

Clinical Trials

NexCAR19

Anti CD19 Gene Therapy for B-cell Lymphoma

A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies

Linperlisib Combined With Chidamide in Patients With PTCL

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

EPOCH

Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma

ALHERT

OHGW-ACP

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

ECAR01

Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

DOBL

PTCy and ATG for MSD and MUD Transplants

REVERSE_2021

The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

FEAD

L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Go-CHOP as the Frontline Therapy for PTCL

Integrative Medicine in Lymphoma Survivors

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies